A Canevari

442 total citations
22 papers, 355 citations indexed

About

A Canevari is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, A Canevari has authored 22 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 8 papers in Oncology and 6 papers in Genetics. Recurrent topics in A Canevari's work include Acute Myeloid Leukemia Research (7 papers), Acute Lymphoblastic Leukemia research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). A Canevari is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Acute Lymphoblastic Leukemia research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). A Canevari collaborates with scholars based in Italy. A Canevari's co-authors include Ercole Brusamolino, Carlo Bernasconi, Mario Lazzarino, Enrica Morra, G. Pagnucco, L. Salvaneschi, M Zucchella, F Tacconi, L Pacchiarini and D Inverardi and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Histopathology.

In The Last Decade

A Canevari

22 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Canevari Italy 11 160 120 90 84 68 22 355
S J Passmore United Kingdom 8 236 1.5× 80 0.7× 32 0.4× 46 0.5× 79 1.2× 10 439
Louise Chevalier France 10 65 0.4× 64 0.5× 29 0.3× 55 0.7× 146 2.1× 17 341
Marie‐Françoise Dresse Belgium 10 255 1.6× 242 2.0× 55 0.6× 36 0.4× 74 1.1× 38 511
Dixie W. Esseltine Canada 13 368 2.3× 206 1.7× 42 0.5× 26 0.3× 64 0.9× 19 587
BC Wolf United States 8 145 0.9× 234 1.9× 99 1.1× 73 0.9× 53 0.8× 9 412
Dennis John Kuo United States 10 53 0.3× 68 0.6× 59 0.7× 79 0.9× 77 1.1× 51 381
R. Fengler Germany 10 280 1.8× 54 0.5× 50 0.6× 91 1.1× 421 6.2× 26 530
Mary Choroszy United States 9 120 0.8× 21 0.2× 33 0.4× 85 1.0× 49 0.7× 14 298
Else Høibraaten Norway 9 185 1.2× 55 0.5× 32 0.4× 36 0.4× 95 1.4× 16 598
Abidemi Adeniji United States 6 42 0.3× 56 0.5× 256 2.8× 152 1.8× 75 1.1× 11 400

Countries citing papers authored by A Canevari

Since Specialization
Citations

This map shows the geographic impact of A Canevari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Canevari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Canevari more than expected).

Fields of papers citing papers by A Canevari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Canevari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Canevari. The network helps show where A Canevari may publish in the future.

Co-authorship network of co-authors of A Canevari

This figure shows the co-authorship network connecting the top 25 collaborators of A Canevari. A scholar is included among the top collaborators of A Canevari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Canevari. A Canevari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lucioni, Marco, Emanuela Boveri, R. Rosso, et al.. (2003). Lymph node reticulum cell neoplasm with progression into cytokeratin‐positive interstitial reticulum cell (CIRC) sarcoma: a case study. Histopathology. 43(6). 583–591. 17 indexed citations
2.
Brusamolino, Ercole, Ester Orlandi, A Canevari, et al.. (1994). Results of CAV regimen (CCNU, Melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease. Annals of Oncology. 5(5). 427–432. 20 indexed citations
3.
Brusamolino, Ercole, Mario Lazzarino, Ester Orlandi, et al.. (1994). Early-stage Hodgkin's disease: Long-term results with radiotherapy alone or combined radiotherapy and chemotherapy. Annals of Oncology. 5. S101–S106. 41 indexed citations
4.
Bernasconi, C, Mario Lazzarino, A Canevari, et al.. (1994). Intensive chemotherapy with or without G-CSF in high risk myelodysplastic syndromes (MDS) or acute leukemia (AL) evolving from MDS: Randomized clinical study. Leukemia Research. 18. 65–65. 2 indexed citations
5.
Pacchiarini, L, et al.. (1992). Effect of Mental Stress on Platelet Function in Normal Subjects and in Patients with Coronary Artery Disease. Pathophysiology of Haemostasis and Thrombosis. 22(3). 138–146. 48 indexed citations
6.
Canevari, A, et al.. (1992). Antithrombin III biological activity and emotional stress in patients with coronary artery disease.. PubMed. 77(2). 180–2. 20 indexed citations
7.
Lazzarino, Mario, Enrica Morra, Ercole Brusamolino, et al.. (1991). Treatment of terminal‐phase chronic myelogenous leukemia with intermediate‐dose cytarabine and hydroxyurea. Hematological Oncology. 9(6). 299–305. 7 indexed citations
8.
Inverardi, D, Mario Lazzarino, Enrica Morra, et al.. (1990). Extramedullary disease in Ph'-positive chronic myelogenous leukemia: frequency, clinical features and prognostic significance.. PubMed. 75(2). 146–8. 29 indexed citations
9.
Orlandi, Ester, G Castelli, Ercole Brusamolino, et al.. (1989). Hemorrhagic and thrombotic complications in polycythemia vera. A clinical study.. PubMed. 74(1). 45–9. 9 indexed citations
10.
Lazzarino, Mario, Enrica Morra, A Canevari, et al.. (1989). Cyclosporine in the treatment of aplastic anaemia and pure red-cell aplasia.. PubMed. 4 Suppl 4. 165–7. 10 indexed citations
11.
Morra, Enrica, Mario Lazzarino, D Inverardi, et al.. (1989). Central nervous system (CNS) leukemia: the role of high dose cytarabine (HDAra-C).. PubMed. 4 Suppl 1. 101–3. 3 indexed citations
12.
Brusamolino, Ercole, Mario Lazzarino, Enrica Morra, et al.. (1989). Combination chemotherapy with alternating MOPP-ABVD in advanced Hodgkin's disease.. PubMed. 74(2). 173–9. 3 indexed citations
13.
Bernasconi, Carlo, Mario Lazzarino, A Canevari, et al.. (1989). Allogeneic versus autologous bone marrow transplantation versus intensive post-remission chemotherapy in acute leukaemias.. PubMed. 4 Suppl 4. 65–8. 4 indexed citations
14.
Castello, A, G. Pagnucco, U Magrini, et al.. (1987). Bone marrow histology in patients with hairy cell leukemia (HCL) treated by human lymphoblastoid interferon.. PubMed. 72(2). 143–9. 1 indexed citations
15.
Bernasconi, C, Mario Lazzarino, Enrica Morra, et al.. (1986). Intensive post-remission consolidation chemotherapy for acute myeloid leukemia (AML) in adults. Leukemia Research. 10(1). 108–108. 1 indexed citations
16.
Morra, Enrica, Mario Lazzarino, D Inverardi, et al.. (1986). Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma.. Journal of Clinical Oncology. 4(8). 1207–1211. 36 indexed citations
17.
Brusamolino, Ercole, L. Salvaneschi, A Canevari, & Carlo Bernasconi. (1984). Efficacy trial of pipobroman in polycythemia vera and incidence of acute leukemia.. Journal of Clinical Oncology. 2(6). 558–561. 36 indexed citations
18.
Morra, Enrica, Mario Lazzarino, Emilio Paolo Alessandrino, et al.. (1984). VP 16-213 and cytosine-arabinoside combination chemotherapy for refractory acute lymphoblastic leukemia in adults. European Journal of Cancer and Clinical Oncology. 20(12). 1471–1475. 10 indexed citations
19.
Brusamolino, Ercole, A Canevari, L. Salvaneschi, Serena Merante, & C Bernasconi. (1984). Efficacy trial of pipobroman in essential thrombocythemia: a study of 24 patients.. PubMed. 68(11). 1339–42. 20 indexed citations
20.
Lazzarino, Mario, Enrica Morra, E. P. Alessandrino, et al.. (1982). Adult acute lymphoblastic leukemia. Response to therapy according to presenting features in 62 patients. European Journal of Cancer and Clinical Oncology. 18(9). 813–819. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S J Passmore Breakdown of academic impact, for papers by Louise Chevalier Breakdown of academic impact, for papers by Marie‐Françoise Dresse Breakdown of academic impact, for papers by Dixie W. Esseltine Breakdown of academic impact, for papers by BC Wolf Breakdown of academic impact, for papers by Dennis John Kuo Breakdown of academic impact, for papers by R. Fengler Breakdown of academic impact, for papers by Mary Choroszy Breakdown of academic impact, for papers by Else Høibraaten Breakdown of academic impact, for papers by Abidemi Adeniji
Rankless by CCL
2026